HomeAI · summaries
Storia in 3 fonti
Trial of early cancer detection test misses primary endpoint; secondary data ‘promising’
CHICAGO — The first randomized trial to evaluate whether a multicancer early detection test using a blood sample could result in diagnosis at earlier stages yielded mixed results.The NHS-Galleri trial did not meet its primary endpoint, failing to show a reduction in combined stage III/stage IV diagnoses of 12 prespecified cancer types.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Trial of early cancer detection test misses primary endpoint; secondary data ‘promising’
CHICAGO — The first randomized trial to evaluate whether a multicancer early detection test using a blood sample could result in diagnosis at earlier stages yielded mixed…
- ·
medpagetoday.com
Multicancer Early Detection Test Fails to Reduce Cancers Detected at Late Stages
However, an increase in the detection of stage I/II cancers was observed
